• 최종편집 2024-03-29(금)

English[영문판]
Home >  English[영문판]

실시간뉴스
  • Evonik Korea establishes strategic partnership with CARIMA and BREEZM
    Evonik Korea establishes strategic partnership with CARIMA and BREEZM     Evonik Korea, CARIMA and BREEZM signed a Memorandum of Understanding(MoU) for strategic cooperation in Seoul, Korea. Mr. Thomas Choi, Korea Cluster Head, Mr. Kwangmin Kim, Vice President of CARIMA and Mr. Wooseok Sung, President of BREEZM, signed the relevant documents on behalf of the three parties. According to MoU, Evonik Korea will deepen cooperation and continue developing proper photopolymer resins. Furthermore, it will be a momentum to speed up the development of DLP 3D printing technology including photopolymer resins.    
    • English[영문판]
    2023-05-10
  • 산업계 및 NGO 단체, 동물대체시험 협력조직(ICCS) 설립
    한국무역협회     전 세계 35 개 이상의 화장품 제조업체, 산업 단체 및 동물보호단체는 동물대체시험(비동물시험) 촉진을 목적으로 하는 ‘화장품안전국제협력(International Collaboration on Cosmetics Safety, ICCS)‘ 조직을 설립했다. 뉴욕에 사무소를 두고 있는 글로벌이니셔티브 ICCS 는 화장품, 퍼스널케어 및 그 성분에 대한 동물대체 안전성평가 채택을 위해 자금을 지원하며, 동물대체시험 가속화를 위한 규제기관에 대한 압력이 증가하는 가운데 설립됐다. 2월 8일 발표된 ICCS 의 목표는 아래와 같다. - 비동물시험 안전성 평가방법 평가 및 개발 - 평가결과 규제기관과 공유 - 비동물시험의 채택 가속화를 위한 산업계 교육 및 훈련 제공 유럽화장품협회(Cosmetics Europe)에 따르면, 이미 많은 프로젝트가 ICCS 를 통해 진행되고 있으며, 최근 미국은 개인위생용품에 대한 대부분의 동물실험을 단계적으로 중단하는 의회 권고 및 화장품 법안이 채택된 바 있다. 캐나다 정부 또한 신규물질에 대한 동물실험을 줄이기 위한 규제 개정을 검토하고 있으며, 캐나다화장품협회(Cosmetics Alliance Canada, CAC)는 2023년 동물대체세계대회(Animal Alternatives World Congress)를 개최할 예정이다. [출처: Chemical Watch]
    • English[영문판]
    • Animal Right
    2023-02-19
  • 하천 내 반려동물 운동·휴식 편의시설 설치 하천법 일부개정법률안 대표발의
        더불어민주당 김회재 의원(전남 여수시을)은 13일 하천 내 반려동물 편의시설을 설치할 수 있도록 하는 내용의 '하천법 일부개정법률안'을 대표 발의했다. 현행법 상 하천구역에서 가축을 방목·사육하는 행위는 금지되어 있다. 그러나 반려동물 가구가 늘어남에 따라 반려동물과 함께 하천을 이용하는 사례가 많아, 이들을 위한 별도의 휴식 등 편의시설이 필요하다는 지적이다. 이에 김 의원은 개정안을 통해 하천구역 내 반려동물 운동·휴식시설을 설치할 수 있도록 규제 조항을 일부 완화했다. 또한 이용 급증에 따라 발생할 환경 오염을 예방하기 위해 오염 실태 주기적 검사, 오염 우려지역 조치 명령 등도 개정안에 포함했다. 국무조정실은 올해 2월 규제개혁신문고에 접수된 국민 건의 중 하천 내 소규모 반려동물 놀이터 등 설치를 대표 사례로 선정해, 2022년까지 법 개정을 추진하겠다 밝힌 바 있다. 김회재 의원은 “반려동물 천만 시대에 많은 시민이 반려동물과 함께 생활하고 있다. 시민과 함께하는 반려동물도 불편함이 없도록 규제를 완화할 필요가 있다”고 지적했다.
    • English[영문판]
    • Animal Right
    2022-05-13
  • '개 식용 문제 논의를 위한 위원회' 운영 연장
               '개 식용 문제 논의를 위한 위원회'는 2021년 12월 9일 출범 후 4월 현재까지 개 식용 문제 해결을 위한 논의를 진행해 왔다.   그동안 활발한 논의를 통하여 개 식용 종식이 시대적 흐름이라는 인식에 공감대를 이루는 성과가 있었으나 아직 합의에는 이르지 못해, 추가적인 논의를 위해 위원회 운영을 2개월 연장하기로 결정하였다.   위원회는 운영 초기부터 개 식용 문제에 대해 이해관계자 등 참여자들 간에 입장 차이가 커서 상호 이해의 폭을 넓히는 것에 중점을 두어 운영하였다.   이에 따라 개 식용 문제 논의에 활용하기 위해 식용 목적 개 사육 현황 등을 조사했으며, 이는 식용 목적 개 관련 통계 자료가 없었던 상황에서 정부가 처음으로 조사했다는 의미가 있다. 또한 개 식용 관련 국민의 인식을 알아보기 위한 설문조사를 실시하였다.   한편 갈등관리 전문기관을 통해 참여 위원과 관련 업계 종사자 등에 대한 심층면접을 실시하여 종식시기, 지원방안 등 그들의 관심 사항과 대립되는 입장을 정확히 진단하여 갈등을 해결하기 위해 노력하였다.     아울러 대만의 개 식용 종식 관련 현지 전문가와 국제 화상회의를 통해 ‘대만의 종식 사례’를 파악하는 등 공감의 폭을 넓혔으며, 이외에도 ‘개 식용 관련 위생적 문제점’, ‘현행법 체계’ 등에 대한 전문가 발표와 논의를 통해 개 식용과 관련한 현 상황을 진단하고 이해를 도모하였다.   참고로 정부는 2021년 11월 25일 국무총리 주재로 ‘국정현안점검조정회의’를 개최하여 '개 식용 문제에 대한 사회적 논의 추진 방향'을 논의하였으며, 그 결과 사회적 논의기구를 관련 동물보호단체, 육견업계, 전문가, 정부 인사 등 21명으로 구성하여 개 식용 문제를 논의하기로 한 바 있다.   정광호 위원장은 "위원회 운영의 기본 원칙인 합의 정신을 실현하기 위해 육견업계와 동물보호단체 등의 입장을 발표할 수 있는 기회를 부여하는 등 충분한 시간을 가지고 논의하는 방식으로 위원회를 운영했으며, 개 식용 종식이 시대적 흐름이라는 인식을 같이하는 성과를 거두었다”라고 강조하면서, "앞으로 그동안 쌓은 위원 간 신뢰와 공감대를 바탕으로 대타협을 도출하기 위해 최선을 다하겠다”라고 밝혔다.
    • English[영문판]
    • Animal Right
    2022-05-06
  • Safety is SKC Evonik Peroxide Korea’s best value.
    Safety is SKC Evonik Peroxide Korea’s best value.     SKC Evonik Peroxide Korea Co., Ltd. (SEPK) in Ulsan Petrochemical Industrial Complex, has achieved 15 times of accident-free goal.  SEPK, maintaining a stable growth in the domestic peroxide industry, declared the start of accident-free goal on December 12, 2003. With the declaration, it has emphasized that safety is the highest value that pursues the sustainable growth of the company and the happiness within the employee’s family. Then by encouraging voluntary participation and activeness of every employee, 15 times of accident-free goal have been achieved on February 19, 2022.   During that period, SEPK has successfully implemented large and various projects such as the triple increase in production capacity with stable operation. SEPK as the sole supplier of the peroxide applicable to HPPO (Hydrogen Peroxide Propylene Oxide) in the country, produces and supplies diverse products including the electronic grade peroxide home and abroad.    Thomas Choi, Representative Director of SEPK, said that Evonik Industries AG, the parent company of SEPK, is operating the system of Evonik Safety Award to ensure accident-free and SEPK won Evonik Emerald Safety Award zero loss time injuries for 25 years) for being accident-free until 2018 after the start-up of the plant in 1993.    Thus, the accident-free goal along with such company safety system has been instrumental in embedding a safety culture in employees and the way of daily life. Choi also added that employees have a strong will to reverify that they are the leader in the peroxide industry based on strong safety by winning Evonik Ruby Safety Award (zero loss time injuries for 30 years) in the near term in December 2023 and achieving 20 times of accident-free goal in November 2028.
    • English[영문판]
    2022-04-12
  • CEO Interview , Mr. Lee Seung Soo (CEO / Infineon technologies Korea)
    CEO Interview , Mr. Lee Seung Soo  (CEO / Infineon technologies Korea)   Interviewer : Alicia Song ( GEBS , Reporter) Interviewee : Mr. Lee Seung Soo  (CEO / Infineon technologies Korea) Reporter   (Hello Everyone, my name is Alicia Song and I am a reporter for GEBS, a foreign company news station in Korea.  I am also the Director of Public Relations at the KOFA. Today, I am honored to be joined with Mr.Lee Seung-Soo, the country manager of the Korean branch of Infineon Technologies)  (Hello Mr. Lee, first of all, thank you very much for accepting this interview.  I know that Infineon Technologies headquarters is based in Germany and Infineon Technologies Korea’s branch is located in Samseong-dong, Gannamgu, Seoul).  Would you please share with us an introduction about Infineon Technologies?) Mr. Lee Seung Soo  :  In the 2020 fiscal year (ending 30 September), Infineon reported revenue of more than €8.5 billion with a workforce of some 46,700 people worldwide. Following the acquisition of the US company Cypress Semiconductor Corporation in April 2020, Infineon is now a global top 10 semiconductor company. We play a key role in shaping a better future – with microelectronics that link the real and the digital world. Our semiconductors enable efficient energy management, smart mobility, as well as secure, seamless communications in an increasingly connected world. Infineon Technologies Korea is located in Samseong-dong, Gangnam and working around 240 employees. Also we set up the sales office in Daegu to provide qualified support for customers in South area. Major customers are Hyundai Motor group, Samsung Electronics and LG Electronics and Infineon Korea have ranked No.1 in Automotive semiconductor area.  Reporter   (Thank you for the introduction. Would you please describe what the organizational culture (OD & Culture) and ideal Talent Style of Infineon Technologies Korea is?) Mr. Lee Seung Soo  :   Infineon Korea respects Korean culture based on IFX head quarter’s structure. All employees are responsible for own work and we place a high value on exchanging necessary feedback each other. There’s a communication format called Leadership dialogue that not only the manager give feedback to the staffs, but the staffs also give feedback to their manager.  Infineon Korea is working on a campaign to call nickname instead of Korean title. We will continue this campaign to make more respectful and equal organizational culture.  Reporter   (Would you please outline the compensation & benefits (C&B) and HR (HRM) system of Infineon Technologies Korea?) Mr. Lee Seung Soo: Infineon Korea provides ‘Flexible spending account’ what employees can use this one like credit card anywhere, anytime. And we are constantly trying to offer the necessary program for employee’s wellness.  Infineon Korea operate global HR system stably. Managers have a performance evaluation with each employee frequently and we managing not only evaluation, but also various training program for employee’s development. Reporter   (How would you describe the labor-management culture of Infineon Technologies Korea?) Mr. Lee Seung Soo:  We have the labor-management council meeting quarterly. Council members from workers are collecting feedbacks regarding all of company life and they put it on the table in labor-management council meeting. All council members discuss new feedbacks and notice the conclusion quarterly.  Reporter   (Would you be able to inform us of any job position currently available at Infineon Technologies Korea or a position that is scheduled to be available in the second half of this year?) Mr. Lee Seung Soo:  Infineon Korea recruits experienced employee time to time. Please refer to the Infineon website for the details of recruiting. www.infineon.kr Reporter  -  (As a successful leader and CEO, it would be great if you could share some advice for working mothers who dream of becoming CEOs of foreign companies in the future?) Mr. Lee Seung Soo:  Most working mothers should take care of both their family and work. They are used to doing two things same time and they know how to use their time efficiently. To finish the work in time, concentration and sensitivity are required. As such, working mothers have many strengths.  I think it’s important to experience various positions in one field if you have a goal to become a CEO. For example, If you’re working as engineer you can try sales position, if you’re working as sales you can try marketing position. Make your unique career focusing on the position what enable to catch the big flow of company’s moving forward. I look forward to meeting many woman CEOs soon. Reporter -  (The world economy has been stunned since the Pandemic.  Would you please highlight some of the real difficulties that currently surround your company industry as well as the future outlook of the industry?) Mr. Lee Seung Soo:  As many people know already Automotive semiconductor supply issue is very serious now days. Semiconductors account for 18% of the total cost of automotive electronics in 2000 but it’s 40% in 2020. The demand has increased significantly but only few foundry companies produce automotive semiconductor because it’s not profitable. It’s expected to continue overeating of automotive semiconductors for a while due to great interest of autonomous driving, electric vehicles and COVID pandemic. To counteract this problem, Infineon is doing the best to find good solutions for our customers. Reporter -  (Lastly, as a mentor who contributes so much to his community, please share with us any wisdom you may have for young job seekers) Mr. Lee Seung Soo:  We are living in an era of rapid change and COVID pandemic has made it harder to get a job. But the economic is slowly recovering and I believe there are opportunities even though it’s a difficult situation. It’s late if you start preparing when the good opportunity happened. You should decide the direction you want to go and make the qualifications and experience to match the job you want. If you decide a job you want to do, I’d like to recommend that you get information about the company you want to work as much as you can. It would be helpful that find the company’s management direction, changes in the industry and company’s outlook. Many companies want you if If you can clearly show your potential and your goals to contribute within the company.
    • English[영문판]
    2022-04-11

실시간 English[영문판] 기사

  • [단독외신] Hypera Pharma Switches to Rimini Street Support for Its SAP Applications
    Hypera Pharma Switches to Rimini Street Support for Its SAP Applications Hypera Pharma Switches to Rimini Street Support for its SAP Applications Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that Hypera Pharma, Brazil’s largest pharmaceutical company, has switched from SAP to Rimini Street Support for its highly customized SAP ECC 6.0 applications, Microsoft SQL Server Database and SAP BusinessObjects software. The company also switched from SAP’s Solution Manager to Rimini Street Watch for SAP, ensuring seamless monitoring for its SAP systems. By switching to Rimini Street Support, Hypera Pharma was able to leverage its significant support savings to fund the company’s business transformation priorities, including expanding the corporate pharmaceutical brand and funding cutting-edge pharmaceutical research and development (R&D) with Hynova, the company’s modern research center in Brazil.Procurement Drives Innovation by Partnering with IT And Business LeadersBased in São Paulo, Hypera Pharma produces popular medicine brands used by over 200 million Brazilians, along with vitamins, nutritional supplements and dermo cosmetics. At the end of 2017, the company announced a new corporate brand with an exclusive focus on the pharmaceutical sector, a competitive industry that demands high investments in innovation and R&D, along with increasing capacity to launch new products and medicines to its consumers more often. This new business direction sparked Hypera Pharma’s leaders to reinvent its operations, realign business priorities and seek out initiatives to drive cost optimization.The decision to move to Rimini Street Support was spearheaded by Hypera Pharma’s heads of procurement and IT, who were tasked with optimizing resources and saw the opportunity to reduce the spending for the company’s high SAP maintenance and support costs and at the same time improve support service. They worked closely to create a business case to demonstrate to the company’s CEO that switching to third-party support would bring security, operational efficiency and savings. The company’s heads of procurement and IT determined that Hypera Pharma should not be locked into the vendor’s time-bound upgrade path to S/4HANA as it did not make sense for the business in the short term. They found little value and no ROI in making this highly disruptive move when their current customized ERP system perfectly met their business needs.“Procurement leaders should feel empowered to bring ideas to company leaders on how their organization can be more strategic and align with business priorities. They can influence decision-makers on how IT initiatives, such as adopting third-party support, adds value and frees up resources for other important projects and innovation,” said Humberto Guimaraes, head of procurement, Hypera Pharma. “Switching to Rimini Street Support is part of a new mindset that has enabled the company to be more relevant in the pharmaceutical industry. With our support savings, we can increase investments across the business, including product R&D, digitalization, process automation and new ERP applications that modernize logistics operations and allow product traceability.”Ultra-Responsive Support with Industry-Leading SLAsHypera Pharma, along with all Rimini Street clients, benefits from the Company’s flexible, premium-level enterprise software support model, including its industry-leading Service Level Agreement (SLA) of 10-minute response times for all critical Priority 1 cases. Clients are also assigned a Primary Support Engineer, backed by a team of functional and technical experts with an average of 15 years’ experience in the client’s specific enterprise software system. Hypera Pharma was using some components of SAP Solution Manager, but working with Rimini Street’s Proactive Support Services team, the company instead implemented Rimini Street Watch for SAP. The solution combines proactive diagnostics and web-based dashboards to help Hypera Pharma identify and mitigate issues before they become critical.“Maintaining our ERP support with SAP meant staying in the comfort zone. Rimini Street showed that the change to third-party support is worthwhile. Now we have reduced our SAP maintenance and support costs, allowing those resources to be directed towards our current business goals. We no longer worry about our ERP support since switching to Rimini Street,” continued Guimaraes.“Modern companies in the digital era like Hypera Pharma, who want to maintain a leadership position in the market, need to optimize their IT costs and find resources to invest in innovation and business transformation,” said Edenize Maron, general manager, Latin America, Rimini Street. “The company’s heads of procurement and IT spearheaded the change to third-party support to generate cost savings that contributed to the organization’s strategic business goals, including modernizing logistics and accelerating R&D to bring products to market quicker. This demonstrates how key it is that all company leaders participate in supporting growth and innovation.”
    • English[영문판]
    2020-10-21
  • [단독외신] Microsoft defends diversity efforts after feds allege discrimination
    [단독외신] Microsoft defends diversity efforts after feds allege discrimination Getty Images Microsoft stood by its efforts to hire and promote more black staffers this week after the feds raised concerns that it was making discriminatory employment decisions. The US Department of Labor took issue with Microsoft’s June pledge to double its number of black and African American managers and other leaders by 2025, warning the tech giant in a letter that it’s forbidden as a federal contractor from discriminating against workers because of their race. The Sept. 29 letter also asked Microsoft to submit records proving it’s not making illegal race-based hiring decisions — an allegation the company said it “emphatically” denies. “We hire and promote the most qualified person. And nothing we announced in June changes that,” Dev Stahlkopf, Microsoft’s corporate vice president and general counsel, said in a blog post Tuesday. “Instead, our continued focus is to work hard to consider and develop the broadest range of qualified candidates for opportunities.” Microsoft was among several large companies that announced effort this summer to address racism and promote opportunities for black people amid massive protests sparked by the police killing of George Floyd. In a June 23 message announcing Microsoft’s initiatives, CEO Satya Nadella said the company would expand leadership development programs for midlevel black employees and pair higher-ranking black staffers with mentors to help them climb the corporate ladder. But the Labor Department’s Office of Federal Contract Compliance Programs indicated Microsoft’s plans may run afoul of the government’s guidelines for promoting diversity in hiring. Officials set an Oct. 29 deadline for the company to submit documents related to its efforts to help black employees. “This statement by the CEO did not reference any established goals in an affirmative action program, and appears to imply that employment action may be taken based on race,” office director Craig Leen wrote in the letter, which the feds provided to The Post. While federal contractors are supposed to set goals for recruiting minorities and women based on availability, “contractors must not engage in discriminatory practices in meeting these goals,” Leen said. Microsoft is confident that its diversity efforts comply with all federal employment laws, Stahlkopf said. The company will provide the Labor Department with the information it requested and defend its approach if needed, he said. “We look forward to helping the [Office of Federal Contract Compliance Programs] understand the legality of our programs as we work towards a shared goal of promoting diversity in full conformity with federal law,” Stahlkopf said.
    • English[영문판]
    2020-10-08
  • [단독외신] Eli Lilly seeks emergency use of its antibody drug for COVID-19
    [단독외신] Eli Lilly seeks emergency use of its antibody drug for COVID-19 LightRocket via Getty Images Drugmaker Eli Lilly says it has asked the US government to allow emergency use of its experimental antibody therapy based on early results from a study that suggested the drug reduced symptoms, the amount of virus, hospitalizations and ER visits for patients with mild or moderate COVID-19. Eli Lilly announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists. Its drug is similar to one that President Trump received on Friday from Regeneron Pharmaceuticals. These medicines supply concentrated versions of specific antibodies to help the immune system clear the coronavirus that causes COVID-19. They’re given as a one-time treatment through an IV. Lilly has already started making one of the two antibodies in its drug, betting that ongoing studies will prove it worthwhile. It’s not clear if the evidence will be viewed as strong enough for the Food and Drug Administration to grant emergency use authorization, as it has done for the antiviral drug remdesivir. The results are an interim look at a mid-stage study in which 112 people received the antibodies and 156 got a placebo. The amount of virus was significantly lower 11 days later in those given the drug — the main goal of the study. Virus also was lower at earlier time points as well. Symptom scores were better at three days. About 5.8 percent of patients given placebo required hospitalization or an emergency room visit versus 0.9 percent of those given the antibodies. The company said there were no serious drug-related side effects.
    • English[영문판]
    2020-10-08
  • [단독외신] US workers file 840,000 new jobless claims as crisis total tops 63 million
    [단독외신] US workers file 840,000 new jobless claims as crisis total tops 63 million Enlarge Image Three disease experts have concerns about the long-term physical and mental health impacts of the prevailing COVID-19 policies.AP Another 840,000 American workers applied for unemployment benefits last week as the coronavirus continued to threaten the US economy, the feds said Thursday. The US Department of Labor’s latest seasonally adjusted figures brought the number of initial jobless claims filed amid the COVID-19 crisis to about 63.6 million — the equivalent of nearly 40 percent of the nation’s total workforce. Last week’s filings fell from the prior week’s revised total of 849,000 but outpaced economists’ expectations for 820,000 new claims. They also marked the sixth consecutive week with filings hovering between 800,000 and 900,000 — still far above the Great Recession’s weekly peak of 665,000. The number may have been driven down by California pausing its processing of unemployment applications for two weeks to work through a backlog of claims and implement anti-fraud technology. Continuing claims, which measure ongoing joblessness on a one-week lag, fell to about 10.9 million in the week ending Sept. 26, continuing their steady decline as more unemployed workers likely exhausted the 26 weeks of benefits that states generally provide. Experts fear the labor market’s recovery from the spring’s massive coronavirus-fueled job losses will falter if the government doesn’t provide another round of aid to the ailing economy. But President Trump pulled the plug on broad stimulus negotiations with Congress this week, raising further questions about when more help will arrive. “Newly reported job losses remain heavy, and it is still unclear at this point whether there will be enough offsetting new job creation to produce a sixth consecutive monthly increase in payrolls in October,” Wrightson ICAP experts wrote in a commentary.
    • English[영문판]
    2020-10-08
비밀번호 :